These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11835216)

  • 1. Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalator.
    Sakagami M; Byron PR; Venitz J; Rypacek F
    J Pharm Sci; 2002 Feb; 91(2):594-604. PubMed ID: 11835216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors.
    Sakagami M; Byron PR; Rypacek F
    J Pharm Sci; 2002 Sep; 91(9):1958-68. PubMed ID: 12210043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition.
    Pang Y; Sakagami M; Byron PR
    Eur J Pharm Sci; 2005; 25(4-5):369-78. PubMed ID: 15979534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solute absorption from the airways of the isolated rat lung. IV. Mechanisms of absorption of fluorophore-labeled poly-alpha,beta-[N(2-hydroxyethyl)-DL-aspartamide].
    Byron PR; Sun Z; Katayama H; Rypacek F
    Pharm Res; 1994 Feb; 11(2):221-5. PubMed ID: 8165179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).
    Pang Y; Sakagami M; Byron PR
    Pharm Res; 2007 Sep; 24(9):1636-44. PubMed ID: 17476466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobramycin disposition in the rat lung following airway administration.
    Li M; Byron PR
    J Pharmacol Exp Ther; 2013 Nov; 347(2):318-24. PubMed ID: 24008335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular weight-dependent lymphatic transfer of fluorescein isothiocyanate-labeled dextrans after intrapulmonary administration and effects of various absorption enhancers on the lymphatic transfer of drugs in rats.
    Hanatani K; Takada K; Yoshida N; Nakasuji M; Morishita Y; Yasako K; Fujita T; Yamamoto A; Muranishi S
    J Drug Target; 1995; 3(4):263-71. PubMed ID: 8821000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solute absorption from the airways of the isolated rat lung. V. Charge effects on the absorption of copolymers of N(2-hydroxyethyl)-DL-aspartamide with DL-aspartic acid or dimethylaminopropyl-DL-aspartamide.
    Sun JZ; Byron PR; Rypacek F
    Pharm Res; 1999 Jul; 16(7):1104-8. PubMed ID: 10450938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confocal imaging of peripheral regions of intact rat lungs following intratracheal administration of 6-carboxyfluorescein, FITC-insulin, and FITC-dextran.
    Pohl R; Thrall RS; Rogers RA; Kramer PA
    Pharm Res; 1999 Feb; 16(2):327-32. PubMed ID: 10100322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved nasal absorption of drugs using poly-L-arginine: effects of concentration and molecular weight of poly-L-arginine on the nasal absorption of fluorescein isothiocyanate-dextran in rats.
    Miyamoto M; Natsume H; Iwata S; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Yamashina M; Morimoto Y
    Eur J Pharm Biopharm; 2001 Jul; 52(1):21-30. PubMed ID: 11438420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols.
    Sakagami M; Kinoshita W; Sakon K; Makino Y
    Arch Toxicol; 2003 Jun; 77(6):321-9. PubMed ID: 12799771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of amiloride-sensitive fluid absorption in rat descending colonic crypts from fluorescence recovery of FITC-labelled dextran after photobleaching.
    Thiagarajah JR; Pedley KC; Naftalin RJ
    J Physiol; 2001 Oct; 536(Pt 2):541-53. PubMed ID: 11600688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size-dependent dextran transport across rat alveolar epithelial cell monolayers.
    Matsukawa Y; Lee VH; Crandall ED; Kim KJ
    J Pharm Sci; 1997 Mar; 86(3):305-9. PubMed ID: 9050797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration polarization of fluorescent dyes in rat descending colonic crypts: evidence of crypt fluid absorption.
    Naftalin RJ; Zammit PS; Pedley KC
    J Physiol; 1995 Sep; 487 ( Pt 2)(Pt 2):479-95. PubMed ID: 8558478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel apparatus for rat in vivo evaluation of dry powder formulations for pulmonary administration.
    Okamoto H; Aoki M; Danjo K
    J Pharm Sci; 2000 Aug; 89(8):1028-35. PubMed ID: 10906726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats.
    Ohtake K; Natsume H; Ueda H; Morimoto Y
    J Control Release; 2002 Aug; 82(2-3):263-75. PubMed ID: 12175742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximal extent of translocation of single-walled carbon nanotubes from lung airways of the rat.
    Matthews IP; Gregory CJ; Aljayyoussi G; Morris CJ; McDonald I; Hoogendoorn B; Gumbleton M
    Environ Toxicol Pharmacol; 2013 May; 35(3):461-4. PubMed ID: 23501606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin disposition in the lung following oral inhalation in humans : a meta-analysis of its pharmacokinetics.
    Sakagami M
    Clin Pharmacokinet; 2004; 43(8):539-52. PubMed ID: 15170368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vasoactive agents on the dermatopharmacokinetics and systemic disposition of model compounds, salicylate and FITC-dextran 4 kDa, following intracutaneous injection of the compounds.
    Yoshida D; Todo H; Hasegawa T; Sugibayashi K
    Int J Pharm; 2008 May; 356(1-2):181-6. PubMed ID: 18294788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.